Acute tubular necrosis screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{CK}} | {{CMG}}; {{AE}} {{CK}} | ||
==Overview== | ==Overview== | ||
Screening for acute tubular necrosis is usually not recommended for asymptomatic individuals. Screening is usually recommended for patients who are at high risk for developing acute tubular necrosis. Screening evaluation includes measurement of serum | [[Screening (medicine)|Screening]] for acute tubular necrosis is usually not recommended for asymptomatic individuals. [[Screening (medicine)|Screening]] is usually recommended for [[Patient|patients]] who are at high risk for developing acute tubular necrosis. Screening evaluation includes measurement of serum [[creatinine]], urine output, [[blood urea nitrogen]], urinary and serum electrolytes. | ||
==Screening== | ==Screening== | ||
* Screening for acute tubular necrosis is usually not recommended for asymptomatic individuals. | * [[Screening (medicine)|Screening]] for acute tubular necrosis is usually not recommended for asymptomatic individuals. | ||
* Screening is usually recommended for patients who are at high risk including | * Screening is usually recommended for [[Patient|patients]] who are at high risk including | ||
** Patients with recent abdominal and cardiac surgery | ** Patients with recent abdominal and cardiac surgery | ||
** Severe [[Hypovolemia|volume depletion]] | ** Severe [[Hypovolemia|volume depletion]] | ||
Line 15: | Line 15: | ||
** [[Comorbidity|Comorbid]] conditions (eg, [[diabetes mellitus]], [[Chronic renal failure|chronic kidney disease]], [[atherosclerosis]]) | ** [[Comorbidity|Comorbid]] conditions (eg, [[diabetes mellitus]], [[Chronic renal failure|chronic kidney disease]], [[atherosclerosis]]) | ||
** Patients who are taking nephrotoxic medication | ** Patients who are taking nephrotoxic medication | ||
* Screening evaluation includes measurement of the following: | * [[Screening (medicine)|Screening]] evaluation includes measurement of the following: | ||
** [[Creatinine|Serum creatinine]] | ** [[Creatinine|Serum creatinine]] | ||
** [[Urine]] volume | ** [[Urine]] volume |
Revision as of 18:27, 22 May 2018
Acute tubular necrosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Acute tubular necrosis screening On the Web |
American Roentgen Ray Society Images of Acute tubular necrosis screening |
Risk calculators and risk factors for Acute tubular necrosis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]
Overview
Screening for acute tubular necrosis is usually not recommended for asymptomatic individuals. Screening is usually recommended for patients who are at high risk for developing acute tubular necrosis. Screening evaluation includes measurement of serum creatinine, urine output, blood urea nitrogen, urinary and serum electrolytes.
Screening
- Screening for acute tubular necrosis is usually not recommended for asymptomatic individuals.
- Screening is usually recommended for patients who are at high risk including
- Patients with recent abdominal and cardiac surgery
- Severe volume depletion
- Hemorrhagic shock
- Rhabdomyolysis
- Sepsis
- Severe pancreatitis
- Comorbid conditions (eg, diabetes mellitus, chronic kidney disease, atherosclerosis)
- Patients who are taking nephrotoxic medication
- Screening evaluation includes measurement of the following:
- Serum creatinine
- Urine volume
- Blood urea nitrogen (BUN)
- Urine sediment and microscopy
- Urine electrolytes
- Serum electrolytes